Publications by authors named "Melina Moschopoulou"
Rheumatology (Oxford)
May 2021
Article Synopsis
- Rituximab (RTX) treatment for rheumatoid arthritis (RA) can lead to hypogammaglobulinemia (HGG), a decrease in immunoglobulin levels (IgG, IgM, IgA), affecting patient outcomes and infection rates.
- In a study of 83 RA patients treated with RTX, nearly 43% experienced HGG, with lower baseline immunoglobulin levels predicting the occurrence of low IgG and low IgM.
- Interestingly, patients who developed low IgM showed better disease activity outcomes, while the development of HGG did not result in a higher rate of serious infections.*
